Submit Deal

STELIS

Summary

Stelis Biopharma is a pure-play, independent biopharmaceutical company. The company can handle all scales from early stages to pre-clinical, clinical and commercial, for recombinant proteins expressed in both microbial and mammalian systems.

Deals Overview

Total Deals2

Valued Deals1

Total Value£ 89 M

Avg. Deal Size£ 89 M

Market Context

Senior Management

Roger Lias
CEO

Sort

25 May 2021|India|Pharmaceuticals

Target: STELIS

Bidder: ROUTE ONE

7 Service Providers

1 Target | 5 Bidder | 1 Vendor

10 Dealmakers

1 Target | 8 Bidder | 1 Vendor

£ 88 M

Value

04 Jul 2023|India|Biotechnology

Target: MULTI-MODAL FACILITY IN BANGALORE

Bidder: SYNGENE

2 Service Providers

1 Bidder | 1 Vendor

7 Dealmakers

5 Bidder | 2 Vendor

n/a

Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy